An Open-Label, Multicenter, Phase 1/2 Clinical Trial of RP1 as a Single Agent and in Combination with Nivolumab in Patients with Solid Tumors [IGNYTE]
RP1;Nivolumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: An Open-Label, Multicenter, Phase 1/2 Clinical Trial of RP1 as a Single Agent and in Combination with Nivolumab in Patients with Solid Tumors [IGNYTE] ### Output: RP1;Nivolumab